Published in Clin Chem on August 01, 1973
Tight-binding inhibitors--IV. Inhibition of adenosine deaminases by various inhibitors. Biochem Pharmacol (1977) 2.13
Practical aspects of reversed-phase liquid chromatography applied to biochemical and biomedical research. Anal Biochem (1979) 1.90
Purine Metabolism in Tetrahymena and Its Relation to Malignant Cells in Mice. Science (1949) 1.83
Diazepam in dentistry. Report on 108 patients. Br Dent J (1968) 1.70
HSP70-2 is required for desynapsis of synaptonemal complexes during meiotic prophase in juvenile and adult mouse spermatocytes. Development (1997) 1.61
Guanylate kinases from human erythrocytes, hog brain, and rat liver. Methods Enzymol (1978) 1.60
Butyramide-utilizing mutants of Pseudomonas aeruginosa 8602 which produce an amidase with altered substrate specificity. J Gen Microbiol (1969) 1.59
Hepatitis B and C in New South Wales prisons: prevalence and risk factors. Med J Aust (1997) 1.57
The performance of microparticle chemically-bonded anion-exchange resins in the analysis of nucleotides. J Chromatogr (1975) 1.49
Three-dimensional structure of human erythrocytic purine nucleoside phosphorylase at 3.2 A resolution. J Biol Chem (1990) 1.46
The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2. Oncogene (1995) 1.43
Single dose of azithromycin for the treatment of genital chlamydial infections in adolescents. J Pediatr (1993) 1.38
Squamous neoplasms of the stomach. Am J Roentgenol Radium Ther Nucl Med (1967) 1.36
Adenosine deaminase from human erythrocytes: purification and effects of adenosine analogs. Biochem Pharmacol (1975) 1.33
Purine nucleoside phosphorylase from human erythrocytes. IV. Crystallization and some properties. J Biol Chem (1969) 1.31
Extraction procedures for use prior to HPLC nucleotide analysis using microparticle chemically bonded packings. J Chromatogr Sci (1977) 1.28
The deoxyribonucleic acid modification enzyme of bacteriophage P1. Biochem J (1972) 1.27
Tight-binding inhibitors-II. Non-steady state nature of inhibition of milk xanthine oxidase by allopurinol and alloxanthine and of human erythrocytic adenosine deaminase by coformycin. Biochem Pharmacol (1975) 1.27
Purine nucleoside phosphorylase. Microheterogeneity and comparison of kinetic behavior of the enzyme from several tissues and species. Biochemistry (1975) 1.25
Nucleotide sequences at the sites of action of the deoxyribonucleic acid modification enzyme of bacteriophage P1. J Mol Biol (1974) 1.24
Purine nucleoside phosphorylase from human erythroyctes. II. Kinetic analysis and substrate-binding studies. J Biol Chem (1968) 1.22
Purine nucleoside phosphorylase from human erythrocytes. I. Purification and properties. J Biol Chem (1968) 1.19
Human erythrocytic purine nucleoside phosphorylase: reaction with sugar-modified nucleoside substrates. Biochemistry (1980) 1.17
Postcatheterization femoral artery injuries: repair with color flow US guidance and C-clamp assistance. Radiology (1992) 1.17
Nucleoside diphosphokinase from human erythrocytes. Methods Enzymol (1978) 1.17
Potent inhibition of muscle 5'-AMP deaminase by the nucleoside antibiotics coformycin and deoxycoformycin. Biochem Pharmacol (1977) 1.13
Incorporation of analog purine nucleosides into the formed elements of human blood: erythrocytes, platelets, and lymphocytes. Ann N Y Acad Sci (1975) 1.13
Evaluation of microparticle chemically bonded reversed-phase packings in the high-pressure liquid chromatographic analysis of nucleosides and their bases. J Chromatogr (1976) 1.11
Isolation and purification of lecithin by preparative high-performance liquid chromatography. J Chromatogr (1990) 1.11
Amino acid substitution in an amidase produced by an acetanilide-utilizing mutant of Pseudomonas aeruginosa. J Gen Microbiol (1972) 1.10
Evolution in action. Nature (1974) 1.06
Identification and quantitation of nucleosides, bases and other UV-absorbing compounds in serum, using reversed-phase high-performance liquid chromatography. II. Evaluation of human sera. J Chromatogr (1979) 1.06
Purine nucleoside phosphorylase. 3. Reversal of purine base specificity by site-directed mutagenesis. Biochemistry (1997) 1.05
Microwave absorption in aqueous solutions of DNA. Nature (1987) 1.04
Purine nucleoside metabolism in the erythrocytes of patients with adenosine deaminase deficiency and severe combined immunodeficiency. J Clin Invest (1976) 1.03
Inhibitors of purine nucleoside phosphorylase, C(8) and C(5') substitutions. Biochem Pharmacol (1982) 1.03
Erythrocytic nucleoside diphosphokinase. II. Isolation and kinetics. J Biol Chem (1966) 1.03
Use of positron emission tomography to study AT1 receptor regulation in vivo. J Am Soc Nephrol (2001) 1.02
The rapid separation of nucleotides in cell extracts using high-pressure liquid chromatography. J Chromatogr (1970) 1.02
Purine nucleoside phosphorylase from human erythrocytes. 3. Inhibition by the inosine analog formycin B of the isolated enzyme and of nucleoside metabolism in intact erythrocytes and sarcoma 180 cells. Mol Pharmacol (1968) 1.02
Multiple markers for lung cancer diagnosis: validation of models for advanced lung cancer. J Natl Cancer Inst (1986) 1.02
HIV prevalence at reception into Australian prisons, 1991-1997. Med J Aust (1999) 1.01
Experience with Hemophilus influenzae pneumonia. Radiology (1966) 1.00
Substrate specificities of 5'-deoxy-5'-methylthioadenosine phosphorylase from Trypanosoma brucei brucei and mammalian cells. Mol Biochem Parasitol (1988) 0.98
Liver nucleotide metabolism in relation to amino acid supply. Biochim Biophys Acta (1972) 0.97
Adenosine deaminase from human erythrocytes. Methods Enzymol (1978) 0.97
5'-Methylthioadenosine phosphorylase-L. Substrate activity of 5'-deoxyadenosine with the enzyme from Sarcoma 180 cells. Biochem Pharmacol (1981) 0.96
Forskolin: a potential antimetastatic agent. Int J Cancer (1983) 0.95
Purine metabolism in primitive erythrocytes. Comp Biochem Physiol B (1973) 0.95
Risk of epithelial ovarian cancer in asymptomatic women with ultrasound-detected ovarian masses: a prospective cohort study within the UK collaborative trial of ovarian cancer screening (UKCTOCS). Ultrasound Obstet Gynecol (2012) 0.94
The temporal sequence of spontaneous repair of osteochondral defects in the knees of rabbits is dependent on the geometry of the defect. J Bone Joint Surg Br (2002) 0.94
Pseudomonas aeruginosa aliphatic amidase is related to the nitrilase/cyanide hydratase enzyme family and Cys166 is predicted to be the active site nucleophile of the catalytic mechanism. FEBS Lett (1995) 0.94
Erythrocytic nucleoside diphosphokinase. 3. Studies with free and phosphorylated enzyme and evidence for an essential thiol group. J Biol Chem (1966) 0.94
Purine nucleoside phosphorylase from human erythrocytes. Methods Enzymol (1978) 0.94
Reactions of reduced nicotinamide adenine dinucleotide in acid: studies by reversed-phase high-pressure liquid chromatography. Biochemistry (1978) 0.93
Nucleotide profiles of the formed elements of human blood determined by high-pressure liquid chromatography. Blood (1973) 0.93
Use of reversed-phase high-performance liquid chromatographic analysis for the determination of provitamin A carotenes in tomatoes. J Chromatogr (1979) 0.92
Growth of Pseudomonas aeruginosa mutants lacking glutamate synthase activity. J Bacteriol (1981) 0.91
Purine nucleoside phosphorylase from human erythrocytes: physiocochemical properties of the crystalline enzyme. Biochemistry (1978) 0.90
The subunit structure of the aliphatic amidase from Pseudomonas aeruginosa. Eur J Biochem (1973) 0.90
Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons. Psychopharmacology (Berl) (2009) 0.89
Platelet aggregation by oral streptococci. FEMS Microbiol Lett (1990) 0.89
The use of chlorfenvinphos for the control of sheep maggot fly. Vet Rec (1965) 0.89
Identification and quantitation of nucleosides, bases and other UV-absorbing compounds in serum, using reversed-phase high-performance liquid chromatography. I. Chromatographic methodology. J Chromatogr (1979) 0.89
An hypothesis on the mechanism of action of 6-thioguanine. Biochem Pharmacol (1967) 0.89
Genomic organization of a mouse glyceraldehyde 3-phosphate dehydrogenase gene (Gapd-s) expressed in post-meiotic spermatogenic cells. Dev Genet (1995) 0.89
Purine metabolism in Schistosoma mansoni. Int J Parasitol (1972) 0.88
High-throughput ultra-high-performance liquid chromatography/tandem mass spectrometry quantitation of insulin-like growth factor-I and leucine-rich alpha-2-glycoprotein in serum as biomarkers of recombinant human growth hormone administration. Rapid Commun Mass Spectrom (2009) 0.88
Changes in nucleoside transport of HL-60 human promyelocytic cells during N,N-dimethylformamide induced differentiation. Cancer Res (1986) 0.88
Characterization of a defect in the pathway for converting 5'-deoxy-5'-methylthioadenosine to methionine in a subline of a cultured heterogeneous human colon carcinoma. J Biol Chem (1984) 0.88
Reaction of 5'-deoxyadenosine and related analogs with the 5'-methylthioadenosine cleaving enzyme of sarcoma 180 cells, a possible chemotherapeutic target enzyme. Biochem Pharmacol (1979) 0.87
Effect of urinary extracts from salt-loaded man on urinary sodium excretion by the rat. Kidney Int (1972) 0.87
Incorporation of nucleosides into the nucleotide pools of human erythrocytes. Adenosine and its analogs. Biochemistry (1973) 0.87
Design of purine nucleoside phosphorylase inhibitors. Fed Proc (1986) 0.86
High prevalence of Chlamydia trachomatis infections in adolescent females not having pelvic examinations: utility of PCR-based urine screening in urban adolescent clinic setting. J Adolesc Health (1997) 0.86
Tight binding inhibitors--VIII. Studies of the interactions of 2'-deoxycoformycin and transport inhibitors with the erythrocytic nucleoside transport system. Biochem Pharmacol (1980) 0.86
High-performance liquid chromatography of nucleotides, nucleosides and bases. J Chromatogr (1981) 0.86
Measurement of human erythrocyte CAI and CAII in adult, newborn, and fetal blood. Clin Biochem (1996) 0.86
Reversed-phase liquid chromatographic separation of 3',5'-cyclic ribonucleotides. Clin Chem (1979) 0.86
Succinic thiokinase. V. Preparation of labeled substrates, their bindings to the enzyme, and isotope exchange studies. J Biol Chem (1967) 0.85
Current state of the art in the HPLC analyses of free nucleotides, nucleosides, and bases in biological fluids. Adv Chromatogr (1980) 0.85
Inhibition of the aliphatic amidase from Pseudomonas aeruginosa by urea and related compounds. Eur J Biochem (1979) 0.85
Evidence that cysteine-166 is the active-site nucleophile of Pseudomonas aeruginosa amidase: crystallization and preliminary X-ray diffraction analysis of the enzyme. Biochem J (1999) 0.85
Repair of postcatheterization femoral pseudoaneurysms by color flow ultrasound guided compression. Am Heart J (1992) 0.85
Dielectric properties of the system bovine albumin: urea: betaine in aqueous solution. Phys Med Biol (1992) 0.85
The separation and direct detection of ceramides and sphingoid bases by normal-phase high-performance liquid chromatography and evaporative light-scattering detection. Anal Biochem (1999) 0.84
NAD-dependent glutamate dehydrogenase from Pseudomonas aeruginosa is a membrane-bound enzyme. FEMS Microbiol Lett (1992) 0.84
Tegument-associated antigen modulation by adult male Schistosoma mansoni. J Immunol (1980) 0.84
Intravenous sedation in dentistry. A study of 55 cases using pentazocine and diazepam. Br Dent J (1975) 0.84
Pseudomonas aeruginosa mutants resistant to urea inhibition of growth on acetanilide. J Bacteriol (1977) 0.84
Arg-188 and Trp-144 are implicated in the binding of urea and acetamide to the active site of the amidase from Pseudomonas aeruginosa. Biochim Biophys Acta (1994) 0.83
Identification and isolation on a large scale of guanylate kinase from human erythrocytes. Effects of monophosphate nucleotides of purine analogs. Biochem Pharmacol (1971) 0.83
Selective analysis for adenosine using reversed-phase high-pressure liquid chromatography. J Chromatogr (1977) 0.83
Reversed-phase liquid chromatographic investigation of UV-absorbing low-molecular-weight compounds in saliva. J Chromatogr (1982) 0.83
Erythrocytic nucleoside diphosphokinase. V. Some properties and behavior of the pI 7.3 isozyme. J Biol Chem (1971) 0.83
Comparison of cell extraction procedures for use with high pressure liquid chromatography. Anal Chem (1972) 0.83